Ken Griffin Rad Net, Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$55.28 - $71.1 $292,984 - $376,829	-5,300 Reduced 15.96%	27,900 $1.94 Million
Q2 2024 Aug 14, 2024	BUY	$46.52 - $61.75 $74,432 - $98,800	1,600 Added 5.06%	33,200 $1.96 Million
Q1 2024 May 15, 2024	BUY	$33.57 - $48.66 $832,536 - $1.21 Million	24,800 Added 364.71%	31,600 $1.54 Million
Q4 2023 Feb 14, 2024	SELL	$25.42 - $37.19 $813,440 - $1.19 Million	-32,000 Reduced 82.47%	6,800 $236,000
Q3 2023 Nov 14, 2023	BUY	$27.3 - $34.99 $649,740 - $832,762	23,800 Added 158.67%	38,800 $1.09 Million
Q2 2023 Aug 14, 2023	SELL	$25.0 - $33.44 $382,500 - $511,631	-15,300 Reduced 50.5%	15,000 $489,000
Q1 2023 May 15, 2023	SELL	$18.18 - $25.07 $52,722 - $72,703	-2,900 Reduced 8.73%	30,300 $758,000
Q4 2022 Feb 14, 2023	BUY	$15.17 - $21.05 $288,230 - $399,950	19,000 Added 133.8%	33,200 $625,000
Q3 2022 Nov 14, 2022	SELL	$17.2 - $23.02 $220,160 - $294,656	-12,800 Reduced 47.41%	14,200 $289,000

317

60.2M

100K

259K

Ticker RDNT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,310,000
Market Cap $4.07B
Description
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modali...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.